The Human Papillomavirus E7 Induces Re-replication in Response to DNA Damage.

Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605-2324 USA.
Journal of Virology (Impact Factor: 4.65). 11/2012; DOI: 10.1128/JVI.02038-12
Source: PubMed

ABSTRACT HPV infection is necessary but not sufficient for cervical carcinogenesis. Genomic instability caused by HPV allows cells to acquire additional mutations required for malignant transformation. Genomic instability in the form of polyploidy has been demonstrated to play an important role in cervical carcinogenesis. We have recently found that HPV-16 E7 oncogene induces polyploidy in response to DNA damage; however the mechanism is not known. Here we present evidence demonstrating that HPV-16 E7 expressing cells have an intact G2 checkpoint. Upon DNA damage, HPV-16 E7 expressing cells arrest at the G2 checkpoint and then undergo re-replication, a process of successive rounds of host DNA replication without entering mitosis. Interestingly, the DNA replication initiation factor Cdt1, whose uncontrolled expression induces re-replication in human cancer cells, is up-regulated in E7 expressing cells. Moreover, down-regulation of Cdt1 impaires the ability of E7 to induce re-replication. These results demonstrate an important role for Cdt1 in HPV E7-induced re-replication and shed light on mechanisms by which HPV induces genomic instability.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of viral infection in cancer was established towards the beginning of 20th century. The study of tumour viruses, their oncogenes and different mecha-nisms employed by these viruses to subvert the growth-suppressive and pro-apoptotic functions of host tumour suppressor genes has laid the foundation of cancer biology. The human tumour viruses induce malignancies after a prolonged latency and in con-junction with other environmental and host factors. The eight known human tumour viruses contribute to nearly 10–15% of the cancers worldwide. Advance-ments in research on virus-related cancers offer a plethora of opportunities to fight cancer by preventing viral spread through vaccination and use of antivirals. Besides, recent developments on viral oncogenic mechanisms should allow development of novel and targeted approaches for control and treatment of virus-associated human cancers.
    Current science 09/2014; 107(5):768-785. · 0.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The high-risk human papillomavirus (HPV) E7 oncogene abrogates DNA damage-induced G1 checkpoint but the mechanism is not fully understood. The G1 kinase Cdk2 is activated in E7-expressing cells. However, whether Cdk2 is required for E7 to abrogate the G1 checkpoint is not known. Accumulating evidence implicates a role for the mitotic Cdk1 in G1/S phase transition in the absence of Cdk2. We therefore examined the expression and requirement of Cdk1 and Cdk2 in the G1 checkpoint abrogation in E7-expressing cells. Although both Cdk1 and Cdk2 were up-regulated in E7-expressing cells upon DNA damage, down-regulation of Cdk1 but not Cdk2 impairs the ability of E7 to abrogate the G1 checkpoint. Our study thus demonstrated an important role for Cdk1 in bypassing the G1 checkpoint in E7-expressing cells. To understand the mechanism by which E7 activates Cdk1, we examined the transcription factor B-Myb. Our studies demonstrated that downregulation of B-Myb reduced the steady-state level of Cdk1 and induced G1 arrest in E7-expressing cells upon DNA damage. In addition, it remains a mystery how E7 promotes cell cycle progression in the presence of Cdk inhibitor p21. As p21 binds Cdk1 with lower affinity than Cdk2, our results suggest a mechanism by which E7 bypasses the inhibitory effect of p21. Nonetheless, our studies demonstrated that p21 still possessed partial ability to arrest cells at G1 phase in E7-expressing cells. These studies shed light on mechanisms by which HPV E7 modulates cell cycle checkpoint.
    Cell cycle (Georgetown, Tex.) 10/2014; 13(20):3249-3259. DOI:10.4161/15384101.2014.953879 · 5.01 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human papillomavirus (HPV), a known etiology of a subset of head-and-neck squamous cell carcinomas (HNCs), causes numerous alterations in normal cellular functions. This article reviews the biology, detection, and treatment of HPV-positive HNC. The role of HPV oncoproteins in tumor development, the natural history of HPV infection, and risk factors for and prevention of transmission of oral HPV are considered. Commonly used methods for detecting HPV infection, including limitations of these methods, are discussed to aid the practicing clinician in using these tests in their clinical practice. Clinical characteristics of HPV-positive HNC, including potential explanations for the improved outcomes seen in patients with HPV-positive HNC, are assessed. Ongoing clinical trials specific for patients with HPV-positive HNC are described, and areas in need of additional research are summarized. Until the results of ongoing trials are known, treatment of HPV-positive HNC should not differ in clinical practice from treatment of similar non-HPV related cancers.
    International journal of radiation oncology, biology, physics 03/2014; 88(4):761–770. DOI:10.1016/j.ijrobp.2013.08.029 · 4.18 Impact Factor


Available from